| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/30/2008 | CA2183050C Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 09/25/2008 | WO2008116145A2 Soluble epoxide hydrolase inhibitors |
| 09/25/2008 | WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| 09/25/2008 | WO2008115098A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114536A1 Dehydroepiandrosterone production promoter and use thereof |
| 09/25/2008 | WO2008114513A1 Prophylactic and/or therapeutic agent for cardiac infarction |
| 09/25/2008 | WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds |
| 09/25/2008 | WO2008113100A1 Method for inducing autophagy |
| 09/25/2008 | WO2008113095A1 Compositions and therapies comprising tranilast compounds and angiotensin-converting enzyme (ace) inhibitors and/or angiotensin receptor blockers (arb) |
| 09/25/2008 | WO2008094574A3 Furanone compounds and methods of making and using the same |
| 09/25/2008 | WO2008084319A3 Novel nucleic acid |
| 09/25/2008 | WO2008077810A3 Spiro-piperidine derivatives |
| 09/25/2008 | WO2008066886A3 Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same |
| 09/25/2008 | WO2008061238A3 Processes for production of 4-biphenylyazetidin-2-ones |
| 09/25/2008 | WO2008052679A3 Use of a fusion protein between a cytokine and an antibody targeting the ed-b fibronectin domain for the treatment of atherosclerosis |
| 09/25/2008 | WO2008018932A3 Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury |
| 09/25/2008 | US20080234621 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content |
| 09/25/2008 | US20080234483 Fasudil-Containing Preparation and Method of Improving Stability Thereof |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234381 1-Hydroxy-naphthalene-2-carboxylic acid(4-cyano-2-trifluoromethoxy-phenyl)-amide; obesity, atherosclerosis, hypertension, type 2 diabetes, dyslipidemia, coronary heart disease, osteoarthritis, gallbladder disease, endometrial cancer, breast cancer, prostate cancer, colon cancer, |
| 09/25/2008 | US20080234376 Prostaglandin E1, a phospholipid with a high purity and a non-proton-providing surfactant; hypertension, thrombosis, asthma, gastric and intestinal ulcers |
| 09/25/2008 | US20080234375 Process for Decreasing Environmental Pollutants in an Oil or a Fat, a Volatile Environmental Pollutants Decreasing Working Fluid, a Health Supplement, and an Animal Feed Product |
| 09/25/2008 | US20080234373 Compound Useful For the Prevention and Treatment of Left Ventricular Hypertrophy in Dialysed Patients |
| 09/25/2008 | US20080234362 Treatment for Asthma and Arthritis and Other Inflammatory Diseases |
| 09/25/2008 | US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 09/25/2008 | US20080234355 Dna methyl transferase inhibitors containing a zinc binding moiety |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234339 Reducing Myocardial Damage and the Incidence of Arrhythmia Arising From Loss, Reduction or Interruption in Coronary Blood Flow |
| 09/25/2008 | US20080234305 Novel Tetrahydropyridine Derivatives |
| 09/25/2008 | US20080234301 Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases |
| 09/25/2008 | US20080234285 Renin inhibitor such as (S),4(S),5(S),7(S) N-(3-amino-2,2-dimethyl-3-oxopropyl)-2,7-di(1-methylethyl)-4-hydroxy-5-amino-8-[4-methoxy-3-(3-methoxy-propoxy)phenyl]-octanamide and PDGF receptor tyrosine kinase inhibitor such as Imatinib, thrombosis, psoriasis, fibrosis, dermatosclerosis, atherosclerosis |
| 09/25/2008 | US20080234282 Especially 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives: 4-{[2-(3,chloro-4-fluorophenyl)-2-piperazin-1-ylethoxy]methyl}-3-methoxy-2-naphthonitrile; neurokinin 1 antagonists; antidepressants |
| 09/25/2008 | US20080234277 Novel aza-pyridopyrimidinone derivatives |
| 09/25/2008 | US20080234266 Squaric Acid Derivatives II |
| 09/25/2008 | US20080234261 Preparation of 1,6-Disubstituted Azabenzimidazoles as Kinase Inhibitors |
| 09/25/2008 | US20080234248 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234203 Use of Substances Having Oxytocin Antagonistic Properties |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 09/25/2008 | US20080233222 Method of Improving Cardiovascular Health |
| 09/25/2008 | US20080233191 Use of ranolazine for elevated brain-type natriuretic peptide |
| 09/25/2008 | US20080233185 Using dimethyl fumarate and/or diethyl fumarate, calcium alkyl fumarate, calcium methyl fumarate and/or calcium ethyl fumarate, zinc methyl fumarate and/or zinc ethyl fumarate, methyl hydrogen fumarate and/or ethyl hydrogen fumarate; sclerodermia, osteochondritis syphilitica (Wegener's disease) |
| 09/25/2008 | US20080233163 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233113 Cardiovascular conditions, ischemia-reperfusion injury, atherosclerosis, inflammatory gastrointestinal disorder, pulmonary condition, musculoskeletal conditions, renal conditions, skin conditions, organ or tissue transplants, nervous system disorders |
| 09/25/2008 | US20080233082 Glycolic acid-lactic acid biodegradable copolymer incorporating signaling factors that signal the repair of vascular stem cells (factors such as ICAM, VCAM, VEGF, CXCR4, matrix metalloproteinases, CTGF, angiogenin, angiopoietin-1, fibroblast growth factors (FGFs), follistatin, G-CSF etc. stents |
| 09/25/2008 | DE102007013812A1 New 1-azacycloalkylimidazole derivatives useful for treating cancer, malaria, cardiovascular diseases or Alzheimer's disease |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/24/2008 | EP1972684A1 Medium for culturing autologous human progenitor stem cells and applications |
| 09/24/2008 | EP1972635A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 09/24/2008 | EP1972200A1 Fluid konjac material, method of producing the same and use thereof |
| 09/24/2008 | EP1971610A1 Salts of clopidogrel with polynions and their use for manufacturing pharmaceutical formulations |
| 09/24/2008 | EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/24/2008 | EP1971596A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 09/24/2008 | EP1971570A2 Process for the preparation of metoprolol and its salts |
| 09/24/2008 | EP1971344A1 A method of treating an acute vascular disorder |
| 09/24/2008 | EP1971336A2 Thrombin receptor antagonists as phophylaxis to complications from cardiopulmonary surgery |
| 09/24/2008 | EP1971228A1 Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
| 09/24/2008 | EP1677779B1 Combination of an antagonist of the tp-receptors and clopidogrel |
| 09/24/2008 | EP1646373B1 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 09/24/2008 | EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis |
| 09/24/2008 | EP1276462B1 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 09/24/2008 | EP1254658B1 Remedies for the treatment of nerve diorders |
| 09/24/2008 | EP1232254B1 Process for the production of a reversibly inactive acidified plasmin composition |
| 09/24/2008 | CN101273046A Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 09/24/2008 | CN101272795A Agent for amelioration of insulin resistance |
| 09/24/2008 | CN101272769A Benzoquinones of enhanced bioavailability |
| 09/24/2008 | CN101272693A Process for production of fermented milk and fermented milk beverage/food |
| 09/24/2008 | CN101270362A Novel serine protease genes related to DPPIV |
| 09/24/2008 | CN101270150A Truncate soluble human vascellum endothelial cell growth factor acceptor, prepraring method and uses thereof |
| 09/24/2008 | CN101270147A Achyranthes bidentata polypeptide, preparing process and uses |
| 09/24/2008 | CN101270110A Novel sulfonyl substituted benzophenone oxide compounds, prepraring method and application thereof |
| 09/24/2008 | CN101270099A Method for preparing N-[2-(1-ethoxycarbonyl-3-phenylpropylamino)-tauryl]-thiazolidinecarboxylic acid and its derivant |
| 09/24/2008 | CN101270086A Sulfonation technique for isoliensinine, arrhythmia resistant function of products produced thereby |
| 09/24/2008 | CN101269216A Oral preparation for reducing brinolase, preparation method and uses thereof |
| 09/24/2008 | CN101269213A Soluble preparation of bone morphogenesis protein-7 and application thereof |
| 09/24/2008 | CN101269204A Cow-bezoar bolus for resurrection and preparation method thereof |
| 09/24/2008 | CN101269203A Quality control testing method for brain-invigorating and heart-soothing capsule |
| 09/24/2008 | CN101269181A Phragmites communis trin kuh-seng soup |
| 09/24/2008 | CN101269177A Mailuoning dropping pills and method for preparing the same |
| 09/24/2008 | CN101269175A Quality control method for comfortable wash liquid for hemorrhoids |
| 09/24/2008 | CN101269158A Medicament combination for treating hypertension, preparation method and quality control method |
| 09/24/2008 | CN101269155A Plaster for treating angitis, phlebitis rankle and preparation method |
| 09/24/2008 | CN101269154A Chinese medicine preparation for treating hypertension |
| 09/24/2008 | CN101269151A Application of radix scrophulariae in preparing medicament for preventing and controlling myocardial hypertrophy, hypertrophic cardiomyopathy and chronic heart failure |
| 09/24/2008 | CN101269142A Application of Chinese medicinal composition in preparing medicament for treating right bundle branch conduction block |
| 09/24/2008 | CN101269141A Chinese medicinal composition for treating raynaud's disease and preparation method thereof |
| 09/24/2008 | CN101269138A Traditional Chinese medicine for treating hemorrhoid |
| 09/24/2008 | CN101269137A Traditional Chinese medicine composition for treating hemorrhoid |
| 09/24/2008 | CN101269136A Antihypelipidemic pressure-release antihyperglycemic eight-treasure tea |
| 09/24/2008 | CN101269135A Technique for extracting and purifying kudzu root, whitethorn, safflower yellow ketones component |
| 09/24/2008 | CN101269130A Chinese medicinal composition for treating hemorrhoid |
| 09/24/2008 | CN101269129A Traditional Chinese medicine for treating hemorrhoid |
| 09/24/2008 | CN101269125A Chinese medicine composition for treating hypertension |
| 09/24/2008 | CN101269124A Plantago asiatica linne polyoses oral preparation, preparation method and uses thereof |